- Latest available (Revised)
- Point in Time (15/02/2018)
- Original (As made)
Point in time view as at 15/02/2018.
There are currently no known outstanding effects for the The Blood Safety and Quality Regulations 2005, Paragraph 2.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
2.3. For autologous donations, the measures marked with an asterisk (*) are recommendations only.U.K.
Component | Quality measures required | Acceptable results for quality measures |
---|---|---|
The required frequency of sampling for all measurements shall be determined using statistical process control | ||
Red cells | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 45g per unit | |
Haemolysis | Less than 0.8% of red cell mass at end of the shelf life | |
Red cells, buffy coat removed | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 43 g per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Red cells, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40g per unit | |
Leucocyte content | Less than 1 x 106 per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Red cells, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 45g per unit | |
Haemolysis | Less than 0.8% of red cell mass at end of the shelf life | |
Red cells, buffy coat removed, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 43g per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Red cells, leucocyte-depleted, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40g per unit | |
Leucocyte content | Less than 1 x 106 per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Red cells, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40g per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Whole blood | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis 450ml +/- 50ml For paediatric autologous whole blood collections – not to exceed 10.5ml per kg body weight |
Haemoglobin (*) | Not less than 45g per unit | |
Haemolysis | Less than 0.8% of red cell mass at the end of the shelf life | |
Platelets, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single donation are permitted within the limits that comply with validated preparation and preservation conditions | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Platelets, apheresis, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single donation are permitted within the limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 1 x 106 per unit | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Platelets, recovered, pooled | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 0.2 x 109 per single unit (platelet-rich plasma method) Less than 0.05 x 109 per single unit (buffy coat method) | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Platelets, recovered, pooled, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 1 x 106 per pool | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Platelets, recovered, single unit | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 0.2 x 109 per single unit (platelet-rich plasma method) Less than 0.05 x 109 per single unit (buffy coat method) | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Platelets, recovered, single unit, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 1 x 106 per unit | |
pH | [F1Minimum 6.4 corrected for 22°C, at the end of the shelf life] | |
Plasma, fresh-frozen | Volume | Stated volume +/- 10% |
Factor VIIIc(*) | Average (after freezing and thawing): 70% or more of the value of the freshly collected plasma unit | |
Total protein | Not less than 50g/l | |
Residual cellular content(*) | Red cells: less than 6.0 x 109/l Leucocytes: less than 0.1 x 109/l Platelets: less than 50 x 109/l | |
Plasma, fresh-frozen, cryoprecipitate-depleted | Volume | Stated volume +/-10% |
Residual cellular content(*) | Red cells: less than 6.0 x 109/l Leucocytes: less than 0.1 x 109/l Platelets: less than 50 x 109/l | |
Cryoprecipitate | Fribrinogen content(*) | Greater than or equal to 140mg per unit |
Fractor VIIIc content (*) | Greater than or equal to 70 international units per unit | |
Granulocytes, apheresis | Volume | Less than 500ml |
Granulocyte content | Greater than 1 x 1010 granulocytes per unit |
Textual Amendments
F1Words in Sch. Pt. 5 para. 2 Table substituted (18.7.2016) by The Blood Safety and Quality (Amendment) Regulations 2016 (S.I. 2016/604), regs. 1, 2(3)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: